期刊文献+

PCI术后应用三联抗凝对冠心病合并房颤患者CRP、PLT、Fg、D-D水平的影响 被引量:1

Effects of Application of Triple Anticoagulation After PCI on CRP,PLT,Fg and D-D Levels of Patients with Coronary Heart Disease Complicated with Atrial Fibrillation
下载PDF
导出
摘要 目的探讨PCI术后应用三联抗凝对冠心病合并房颤患者CRP、 PLT、 Fg以及D-D水平的影响。方法 120例接受PCI手术的冠心病合并房颤患者随机分为两组各60例。PCI术后,对照组行二联抗凝治疗,观察组行三联抗凝治疗。比较两组的实验室指标水平,以及不良事件发生情况。结果治疗6个月后,两组的CRP、 PLT、 Fg以及D-D水平均显著下降,且观察组的各项指标均显著低于对照组(P <0.05)。观察组的心血管事件及下肢DVT发生率显著低于对照组(P <0.05)。两组的出血事件发生率比较,差异无统计学意义(P>0.05)。结论 PCI术后应用三联抗凝可改善冠心病合并房颤患者的CRP、 PLT、 Fg、 D-D水平,促进血液微循环,降低心血管事件及下肢DVT发生率。 Objective To explore the effects of application of triple anticoagulation after PCI on CRP,PLT,Fg and D-D levels of patients with coronary heart disease(CHD)complicated with atrial fibrillation(AF).Methods 120 patients with CHD complicated with AF who underwent PCI were randomly divided into two groups,with 60 cases in each group.After PCI,the control group received double anticoagulation therapy,while the observation group received triple anticoagulation therapy.The levels of laboratory indicators and the incidences of adverse events were compared between the two groups.Results After 6 months of treatment,the levels of CRP,PLT,Fg and D-D in both groups significantly decreased,and the indicators in the observation group were significantly lower than those in the control group(P<0.05).The incidence of cardiovascular events and lower limb DVT in the observation group was significantly lower than that in the control group(P<0.05).No significant difference was found in the incidence of bleeding events between the two groups(P>0.05).Conclusions The application of triple anticoagulation after PCI can improve the CRP,PLT,Fg and D-D levels of patients with CHD complicated with AF,promote blood microcirculation,and reduce the incidence of cardiovascular events and lower limb DVT.
作者 李明 于群 刘影倩 LI Ming;YU Qun;LIU Yingqian(Department of Thoracic Surgery,Zhuhai Fifth People's Hospital,Zhuhai 519055,China;Department of General Surgery,Zhuhai Fifth People's Hospital,Zhuhai 519055,China)
出处 《临床医学工程》 2020年第8期1031-1032,共2页 Clinical Medicine & Engineering
关键词 冠心病 房颤 三联抗凝 PCI CRP PLT FG D-D 心血管事件 Coronary heart disease Atrial fibrillation Triple anticoagulation PCI CRP PLT Fg D-D Cardiovascular events
  • 相关文献

参考文献7

二级参考文献79

  • 1Vassallo P,Trohman RG. Prescribing amiodarone: an evidence-basedreview of clinical indications [J] . JAMA, 2007, 298 (11) : 1312-1322. 被引量:1
  • 2Patel C, Yan GX, Kowey PR. Dronedarone [J] . Circulation, 2009,120 (7) : 636-644. 被引量:1
  • 3Connolly SJ, Camm AJ, Halperin JL, et al. Dronedarone in high-riskpermanent atrial fibrillation [J] . N Engl J Med, 2011, 365 (24):2268-2276. 被引量:1
  • 4Chaitman BR. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions [J] . Circulation, 2006,113(20): 2462-2472. 被引量:1
  • 5Belardinelli L, Shryock JC, Fraser H. Inhibition of the late sodium cur-rent as a potential cardioprotective principle: Effects of the late sodiumcurrent inhibitor ranolazine [J] . Heart, 2006, 92 (4) : iv6-ivl4. 被引量:1
  • 6Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al. Effects ofranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomizedtrial [J] . JAMA, 2007, 297 (16) : 1775-1783. 被引量:1
  • 7Scirica BM, Belardinelli L, Chaitman BR, et al. Effect of ranolazine onatrial fibrillation among patients with Non-ST elevation acute coronarysyndromes: Observations from the MERLIN -TIMI 36 Trial [J].Europace, 2015, 17 (1) : 21-37. 被引量:1
  • 8Hammond DA, Smotherman C, Jankowski CA, et al. Short-course ofranolazine prevents postoperative atrial fibrillation following coronaryartery bypass grafting and valve surgeries [J] . Clin Res Cardiol, 2015,104 (5) : 410-417. 被引量:1
  • 9Murdock DK, Kaliebe J, Larrain G. The use of ranolazine to facilitateelectrical cardioversion in cardioversion-resistant patients: a case se-ries [J] . Pacing Clin Electrophysiol, 2012, 35 (3) : 302-307. 被引量:1
  • 10Scirica BM, Braunwald E, Belardinelli L, et al. Relationship betweennonsustained ventricular tachycardia after non -ST -elevation acut ecoronary syndrome and sudden cardiac death: observations from themetabolic efficiency with ranolazine for less ischemia in non -ST -elevation acute coronary syndrome -thrombolysis in myocardial infarc-tion 36 (MERLIN-TIMI 36) randomized controlled trial [J] . Circula-tion, 2010,122 (5) : 455-462. 被引量:1

共引文献42

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部